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Abstract
Introduction Both C-reactive protein (CRP) and procalcitonin (PCT) are accepted sepsis markers.
However, there is still some debate concerning the correlation between their serum concentrations and
sepsis severity. We hypothesised that PCT and CRP concentrations are different in patients with
infection or with no infection at a similar severity of organ dysfunction or of systemic inflammatory
response.
Patients and methods One hundred and fifty adult intensive care unit patients were observed
consecutively over a period of 10 days. PCT, CRP and infection parameters were compared among
the following groups: no systemic inflammatory response syndrome (SIRS) (n = 15), SIRS (n = 15),
sepsis/SS (n = 71) (including sepsis, severe sepsis and septic shock [n = 34, n = 22 and n = 15]),
and trauma patients (n = 49, no infection).
Results PCT and CRP concentrations were higher in patients in whom infection was diagnosed at
comparable levels of organ dysfunction (infected patients, regression of median [ng/ml] PCT = -0.848
+ 1.526 sequential organ failure assessment [SOFA] score, median [mg/l] CRP = 105.58 + 0.72
SOFA score; non-infected patients, PCT = 0.27 + 0.02 SOFA score, P < 0.0001; CRP = 84.53 - 0.19
SOFA score, P < 0.005), although correlation with the SOFA score was weak (R = 0.254, P < 0.001
for PCT, and R = 0.292, P < 0.001 for CRP). CRP levels were near their maximum already during lower
SOFA scores, whereas maximum PCT concentrations were found at higher score levels (SOFA score
> 12).
PCT and CRP concentrations were 1.58 ng/ml and 150 mg/l in patients with sepsis, 0.38 ng/ml and
51 mg/l in the SIRS patients (P < 0.05, Mann–Whitney U-test), and 0.14 ng/ml and 72 mg/l in the
patients with no SIRS (P < 0.05). The kinetics of both parameters were also different, and PCT
concentrations reacted more quickly than CRP.
Conclusions PCT and CRP levels are related to the severity of organ dysfunction, but concentrations
are still higher during infection. Different sensitivities and kinetics indicate a different clinical use for
both parameters.
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The critically ill patient frequently presents similar clinical pic-
tures in infection, organ dysfunction, and in the various severi-
ties of a systemic inflammatory response syndrome (SIRS).
Also, differences in body temperature (BT), heart rate, white
blood cell (WBC) count, and respiratory rate often are small.
As a consequence, diagnosis of sepsis and infection can be
difficult: positive bacteriological samples may be late or
absent, the clinical interpretation of local colonisation may be
ambiguous, and traditional markers of infection such as BT
and WBC count may be unspecific.
Other parameters such as C-reactive protein (CRP) and pro-
calcitonin (PCT) have been considered to evaluate the evolu-
tion of infections and sepsis in critically ill patients [1-5].
However, induction of these parameters is also multifactorial.
Infection, severe systemic inflammation, organ dysfunction, tis-
sue trauma, and many other aetiologies cause their induction
(for reviews see [6,7]). To distinguish organ-dysfunction-
related induction and infection-related CRP or PCT response
can be difficult. Various recently published studies indicate
that there is a significant relationship of PCT not only to infec-
tion and systemic inflammation, but also to organ dysfunction
as well as various types of tissue trauma [7-12].
Given this information, a retrospective look at former studies
indicates that classification according to the severity of organ
dysfunction is not reported in every study, or that groups with
infection or with no infection were not balanced well according
to the severity of organ dysfunction. Since various conditions
are known to induce a PCT response in vitro and in vivo, and
the source of PCT production is not finally known, the role of
infection in patients with multiple organ dysfunction syndrome
should be further elucidated.
In the case of CRP, no definite correlation between infection
and change of plasma concentrations have been documented
[2], but some authors have reported that daily measurement of
CRP is useful in the detection of sepsis and that it is more sen-
sitive than currently used markers, such as BT and WBC
count [13]. PCT also has been proposed as an indicator of the
presence of infection [3-5], and definitively as a useful marker
of the severity of sepsis [4,14,15]. However, in the clinical
context it is often difficult to define CRP or PCT as an inde-
pendent variable for diagnosis of infection due to the multiple
causes of induction and the comorbidity of infection, systemic
inflammation, organ dysfunction, endotoxinaemia, bacterial
translocation, and tissue trauma in many critically ill patients. A
variety of recent publications demonstrated conditions without
infection that induce PCT (e.g. cardiogenic shock, major sur-
gery including cardiac surgery, accidental trauma, pancreati-
tis, or burn trauma) [8,10-12,16-19].
Knowing these data, we sought to further define the features
of CRP and PCT. We have analysed these features in critically
ill patients with systemic inflammation who had infection (sep-
sis, severe sepsis, and septic shock) or had no infection at var-
ious severities of organ dysfunction (sequential organ failure
assessment [SOFA] score), or a systemic inflammatory
response (SIRS, and no SIRS). We have also compared the
profile and kinetics of both parameters. Patients with trauma
without infection were analysed as a separate group, since
trauma may induce a significant response of PCT and CRP in
some patients.
Materials and methods
From May 1999 to April 2000, all adult patients consecutively
admitted to the mixed medicosurgical intensive care unit (ICU)
at the Carlo Poma Hospital in Mantova, Italy were studied.
Neurosurgical and elective surgical patients without complica-
tions were excluded. The study was approved by the local Eth-
ics Committee and care of the patients was directed by the
same existing protocols.
At the time of admission and every day thereafter, signs and
symptoms, clinical and laboratory data including PCT, CRP,
BT, WBC count, arterial blood-gas analysis, and lactate levels
were collected and scheduled. Samples were collected for
cultures depending on the clinical symptoms. We used the
American College of Chest Physicians/Society of Critical
Care Medicine Consensus Conference definition of sepsis to
identify patients with sepsis, severe sepsis, septic shock, and
SIRS [20]. The SOFA score was used to describe a sequence
of complications and the severity of organ dysfunction in criti-
cally ill patients [21]. The grading of sepsis was assessed with
the sepsis score [22].
On the basis of clinical, laboratory and bacteriological find-
ings, the patients were split into four groups and studied for 10
days: trauma group, patients admitted with trauma; SIRS
group, patients who developed clinical signs of systemic
inflammatory response [23] but had no defined source of
infection; SEPSIS/SS group, patients with SIRS and a known
source of infection and/or positive blood cultures (these
patients were divided into sepsis, severe sepsis, and septic
shock according to American College of Chest Physicians/
Society of Critical Care Medicine criteria); and no SIRS group,
medicosurgical patients without trauma or SIRS.
Infection was defined when clinical signs of systemic inflam-
matory response were present, determined by a definable
source of infection (microbiology confirmed) and/or positive
blood cultures.
Day 1 (T1) was defined as the first observational day at admis-
sion, and the next day was named T2 (day 2), then T3 (day 3),
and so on. Collected data regarding the groups were double
blinded to the results of the serum PCT level.
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Dade Behring, Marburg, Germany). Samples for PCT determi-
nation were stored at -20°C for < 2 weeks, and measurement
was performed by immunoluminometric assay (B.R.A.H.M.S.;
Diagnostica AG, Hennigsdorf/Berlin, Germany and LUMItest
PCT ILMA-kit; Liamat Instruments, BYK Gulden, Italy). Lactate
levels were measured using a blood-gas analyser (model 865;
Ciba Corning Diagnostics Corp., Medfield, MA, USA).
Statistical analysis
The results are presented as the median and 25th/75th per-
centiles (data non-normally distributed). The Kolmogorov–
Smirnov test was used to assess sample distributions. To
compare two independent samples we used an unpaired t-test
or the Mann–Whitney U-test (data non-normally distributed).
To compare three independent groups we used analysis of
variance or the Kruskal–Wallis test (data non-normally distrib-
uted) with Bonferroni corrections. Serial sample data from the
same patient were compared by Wilcoxon's test for non-para-
metric paired samples. We used the chi-square test to com-
pare proportions. Receiver operating characteristic (ROC)
curves and the areas under the respective curve were calcu-
lated. The maximum PCT and CRP concentrations, the maxi-
mum SOFA score and sepsis score in the first 24 hours (T1)
were used to calculate the ROC curves. Among the PCT,
CRP, lactate and SOFA score, Pearson's correlation and the
regression formula were calculated (y = a + bx).
For comparison, the slope of the regression lines was calcu-
lated using analysis of variance, and the crossing of the regres-
sion line at the y axis was calculated with analysis of
covariance.
P < 0.05 was considered significant. Statistical calculations
were performed with SPSS statistical software (version 10.0;
SPSS Inc., Chicago, IL, USA).
Results
One hundred and fifty patients were studied: 15 no SIRS
patients (respiratory, renal, and neurologic failure), 15 SIRS
patients (two with respiratory failure, seven with cardiac failure,
myocardial infarction, and pulmonary embolism, four with neu-
rological diseases and stroke, and two with poisoning), 49
trauma patients (37 with multiple trauma and 12 with head
injury only) and 71 sepsis/SS patients (26 with pneumonia, 24
with peritonitis, 13 with bloodstream infection, seven with soft
tissue infection, and one with bacterial meningitis – 34 with
sepsis, 22 with severe sepsis, and 15 with septic shock). A
total of 1222 observation days (mean, 8 days; range, 1–10
days) were evaluated. The age range was from 15 to 89 years
(median age, 59.2 years), and 96 patients were male (64%).
Twenty-nine patients died with a mortality rate of 19% (eight
patients with septic shock, six patients with severe sepsis and
six patients with sepsis, four patients with SIRS, three patients
with no SIRS, and two patients with trauma).
The CRP, PCT and Sepsis score values were higher both in
sepsis and sepsis/SS score groups versus SIRS and no SIRS
groups (P < 0.05). The SOFA score and PCT level were
higher in septic shock versus severe sepsis versus sepsis (P
< 0.05). The lactate plasma level was higher in septic shock
versus severe sepsis (P < 0.05), and the sepsis score was
higher in severe sepsis versus sepsis (P < 0.05). The values
at admission in the groups are presented in Table 1.
The area under the ROC curve in the diagnosis of sepsis ver-
sus SIRS was 0.794 for CRP (cutoff, 90 mg/l) and was 0.731
for PCT (cut-off, 1.2 ng/ml) (P < 0.05) (Fig. 1). The area under
the ROC curve in the diagnosis of sepsis/SS, excluding the
trauma group (the diagnosis at admission is obvious), was
0.866 for PCT, 0.755 for CRP, 0.862 for sepsis score, and
0.731 for SOFA (P < 0.05 for all) (Fig. 2).
The admission PCT values of trauma patients who developed
sepsis (not included in sepsis/SS) were higher than in patients
without septic complications: 3.4 (2.63–12.71) ng/ml versus
1.2 (0.5–5.2) ng/ml (P < 0.05). Trauma patients at the
moment of septic complications did not present a significant
increase of plasma CRP values, but did present an early and
quick significant increase of PCT, as compared with concen-
trations measured 1 day prior to the diagnosis: 153 ± 89 mg/
l versus 174 ± 84 mg/l for CRP (P = not significant) and 0.85
(0.45–1.14) ng/ml versus 2.1 (1.01–6.14) ng/ml for PCT (P <
0.05).
The time courses of the median CRP level, PCT level, SOFA
score and sepsis score in the sepsis group were analysed
(Fig. 3). CRP and PCT levels were significantly higher in the
sepsis group versus the SIRS and no SIRS groups from T1 to
T5 (P < 0.05). The maximum serum PCT levels were seen 1
day earlier (T1) than CRP in sepsis/SS (3 ng/ml; range, 1.48–
15.26 ng/ml), at T1 in the SIRS (0.38 ng/ml; range, 0.16–0.93
ng/ml) and the no SIRS groups (0.14 ng/ml; range, 0.07–0.29
ng/ml), and at T2 in the trauma group (1.41 ng/ml; range, 0.4–
4.2 ng/ml).
The maximum serum CRP levels were at T2–T3 in the sepsis/
SS group (165 mg/l; range, 107–216 mg/l), at T3 in the no
SIRS group (89 mg/l; range, 37–122 mg/l), at T5 in the SIRS
group (103 mg/l; range, 38–154 mg/l) and at T8 in the trauma
group (116 mg/l; range, 67–158 mg/l), which was later com-
pared with PCT.
In the sepsis/SS group only the SOFA score at admission was
predictive of outcome (Fig. 4): non-survivors achieved higher
scores than survivors (10.5; range, 5.7–14.2 versus 5; range,
4–7; P < 0.001).
Correlations with SOFA score
When PCT, CRP and lactate concentrations were analysed
according to the various severities of organ dysfunction meas-
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and increasing values of both parameters during more severe
stages of organ dysfunction were observed.
In nontrauma patients, correlation of the PCT level and SOFA
score was 0.254, that of the CRP level and SOFA score was
0.292, and the correlation was 0.378 for lactate (P < 0.001
for all; Pearson's correlation). To indicate the different induc-
tion characteristics of the parameters, concentrations of each
parameter during four different groups of SOFA score are pre-
sented in Table 1. PCT and lactate concentrations were low in
patients with low score values of the SOFA score, and maxi-
mum concentrations were observed only at higher score val-
ues, indicating multiple organ dysfunction, especially at SOFA
> 12. On the contrary, CRP values were near their maximum
levels already during minor score values (< 12), and did not
increase much further in patients with higher score values.
Lactate plasma levels had only a limited range of
concentrations (10th/90th percentiles from 0.7 at lower
SOFA scores to 6.5 at higher scores).
Correlation and regression were calculated for the infection
parameters and SOFA score in noninfected and infected
patients. In both groups, lactate values correlated weakly with
the SOFA score: 0.35 and 0.382, respectively, in noninfected
and infected patients (P < 0.001); in the infection group, cor-
relation was 0.247 for PCT and 0.286 for CRP (P < 0.001).
When measurements at time points with and without infection
were compared, CRP and PCT concentrations were more
increased in patients with infection, indicated by the higher
slope (b) of the regression line, at similar SOFA score levels
(P < 0.02 for PCT, and P < 0.001 for CRP).
The regression (y = a + bx) for the PCT level and SOFA score
was PCT = 0.27 + 0.02 SOFA score in noninfected patients
and was PCT = -0.848 + 1.526 SOFA score in infected
patients (Fig. 5). The respective values for the CRP level were
CRP = 84.53 - 0.19 SOFA score and CRP = 105.58 + 0.72
SOFA score (Fig. 6).
Crossing of the regression line at the y axis for PCT is low, but
it is high (84/105 mg/l) for CRP, indicating the higher reactivity
of this parameter in the less severe stages of disease as com-
pared with PCT. Accordingly, when CRP and PCT were cate-
gorised according to four groups of the SOFA score in
noninfected and infected patients (not including trauma
patients), lower PCT concentrations despite higher score lev-
els of organ dysfunction (SOFA score) were seen in patients
without infections. However, the low number of measurements
in patients with high SOFA score values who had no infection
limits further statistical evaluation of the data (Table 2).
Discussion
Various studies report higher PCT and CRP values in patients
with bacterial infection as compared with those with viral infec-
tion, autoimmune disorders, or other nonbacterial infection-
Table 1
Procalcitonin (PCT), C-reactive protein (CRP), lactate and sepsis score values at different categories of the sequential organ failure 
assessment (SOFA) score and severity of systemic inflammation according to American College of Chest Physicians/Society of 
Critical Care Medicine (ACCP/SCCM) criteria
SOFA PCT (ng/ml) CRP (mg/l) Lactate (mmol/l) Sepsis score
Category of SOFA score (number of observations)
1–6 (n = 557) 3 (2/5) 0.37 (0.12/1.2) 101 (53/161) 1.24 (0.96/1.6) 6 (3/10)
7–12 (n = 156) 9 (7/10) 2.55 (0.85/9.95) 140 (65/209) 1.74 (1.2/2.43) 13 (10/16)
13–18 (n = 31) 14 (13/15) 8.5 (3.3/28.4) 180 (115/219) 3 (2.34/3.83) 21.5 (16.25/25.75)
19–24 (n = 13) 19.5 (19/20) 23.24 (2.28/50.92) 154 (9.6/308) 3.7 (3.5/5) 25(24.25/25.75)
Category according to ACCP/SCCM criteria (number of patients)
No SIRS (n = 15) 3 (2–4.5) 0.14 (0.07–0.29) 72 (20–125) 1.26 (0.64–1.38) 3 (0–5.5)
SIRS (n = 15) 4 (2.25–8.25) 0.38 (0.16–0.93)* 51 (19.5–80.5) 2.13 (1.14–2.93)* 3.5 (2–8.25)
Sepsis/SS (n = 71) 6 (4–9) 3 (1.48–15.26)** 164 (75–222)** 2.2 (1.27–3.74) 11 (7–17)**
Sepsis (n = 34) 4.5 (3–6) 1.58 (0.41–3) ** 150 (71–209)** 1.37 (1–2.61) 8.5 (3.75–12.25)**
Severe sepsis (n = 22) 7 (6–8.25)† 5.58 (1.84–32.93)† 159 (75–209) 2.19 (1.73–2.93) 14.5 (9.25–19.75)†
Septic shock (n = 15) 11 (9–15)d 13.1 (6.1–42.2)‡ 195 (75–272) 3.7 (2.6–6.4)‡ 15 (13.5–19.5)
Trauma patients (n = 49) 5 (3–8) 1.4 (0.3–5.1) 40 (16–150) 2.7 (1.7–5) 3 (0–5.3)
All patient groups without trauma were evaluated. Trauma patients were in a separate group. Data presented as median values (lower and upper 
quartiles). SIRS, systemic inflammatory response syndrome. * P < 0.05 versus no systemic inflammatory response syndrome (No-SIRS), ** P < 
0.05 versus SIRS, † P < 0.05 versus sepsis, ‡ P < 0.05 versus severe sepsis.
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sis, severe sepsis or septic shock with documented infections
[15]. The role of PCT and CRP in the diagnosis of infection
was evaluated [14]; PCT and CRP were significantly higher in
patients with infection as compared with those without infec-
tion. However, beside infection-related induction of PCT, there
are plenty of data indicating an inflammation-related induction
of PCT [10-12,16-18]. Various further stimuli, meanwhile, are
known to induce PCT, CRP, and cytokines beside bacterial
endotoxins or bacterial products [29-31]. A detailed analysis
of the influence of the various severities of organ dysfunction
has not been conducted in these studies. A relation of PCT
and various severities of organ dysfunction has been
published previously, supporting the observation of organ dys-
function and systemic inflammation-related induction of PCT
and CRP. However, in this previous study by Meisner and col-
leagues, patients were not separated according to the pres-
ence of infection or its absence [9].
In the present study, not only plasma levels of PCT and CRP
were compared at the various severities of systemic inflamma-
tion and sepsis, but also plasma levels in patients with and
without infection at different levels of organ dysfunction,
assessed by the SOFA score [21,32]. Furthermore, we have
described the kinetics of both parameters in critically ill
patients with trauma, with SIRS and with sepsis (SIRS and
infection).
PCT and CRP concentrations, despite organ dysfunction,
were higher in patients with infection, indicated by the higher
slope of regression and higher plasma levels at comparable
categories of the SOFA score in patients with infection, and
the higher values in corresponding categories of the SOFA
score. These data indicate that PCT and CRP indeed are
parameters that, in particular, are more strongly induced in
patients in whom the systemic inflammatory response is
complicated by infection, or vice versa. When the data were
categorised according to four groups of the SOFA score, data
were valid only for lower score groups (SOFA < 12), since the
number of patients analysed without infection was too small
for statistical analysis during more severe stages of organ
dysfunction.
We also report different further features of CRP and PCT.
CRP concentrations were high already during the less severe
stages of organ dysfunction and systemic inflammation, but
values were not much further increased during the more
severe stages of disease. On the contrary, PCT levels espe-
Figure 1
Receiver operating characteristic (ROC) curves (95% confidence inter-val) for the pred ction of sepsi  versus systemic inflammatory respo se syndrome
val) for the prediction of sepsis versus systemic inflammatory response 
syndrome. C-reactive protein (CRP) (thin dashed line), 0.794 (0.644–
0.944) (standard error, 0.05; P < 0.05); best cut-off, 90 mg/l; sensitiv-
ity, specificity, negative predictive value (NPV), and positive predictive 
value (PPV), 74, 85, 92, and 53. Procalcitonin (PCT) (thick solid line), 
0.731 (0.587–0.875) (standard error, 0.05; P < 0.05); best cut-off, 1.2 
ng/ml; sensitivity, specificity, NPV, and PPV, 63, 87, 92, and 51. Sepsis 
score (thin solid line), 0.701 (0.534–0.869) (standard error, 0.08; P = 
0.055). Sequential organ failure assessment score (thick dashed line), 
0.505 (0.299–0.711) (standard error, 0.105; P = 0.96).
Figure 2
Receiver operating characteristic (ROC) curves (95% confidence inter-val) for the pred ction of sepsi /SS; the tra ma group was excluded (diagnosis at a mission was obvious)
val) for the prediction of sepsis/SS; the trauma group was excluded 
(diagnosis at admission was obvious). Procalcitonin (PCT) (thick solid 
line), 0.866 (0.79–0.93) (standard error, 0.04; P < 0.001); best cut-off, 
1.11 ng/ml; sensitivity, specificity, negative predictive value (NPV), and 
positive predictive value (PPV), 79, 85, 92, and 65. Sepsis score (thin 
dashed line), 0.862 (0.78–0.93) (standard error, 0.04; P < 0.001); 
best cut-off, 5.5; sensitivity, specificity, NPV, and PPV, 66, 71, 66, and 
71. C-reactive protein (CRP) (thin solid line), 0.755 (0.64–0.86) (stand-
ard error, 0.05; P < 0.001); best cut-off, 128 mg/l; sensitivity, specifi-
city, NPV, and PPV, 67, 82, 90, and 51. Sequential organ failure 
assessment (SOFA) score (thick dashed line), 0.731 (0.61–0.84) 
(standard error, 0.06; P < 0.001); best cut-off, 4.5; sensitivity, specifi-
city, NPV, and PPV, 73, 68, 86, and 47.
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sis or septic shock.
Also the kinetics were different for both parameters. PCT con-
centrations had their maximum levels prior to those of CRP,
and the concentrations more rapidly declined as compared
with CRP. Various aspects are thus required to describe the
clinical usefulness of such parameters for the diagnosis of
sepsis and infection in critically ill patients.
In the present study, higher levels of PCT and CRP in patients
with sepsis as compared with those with SIRS only were also
reported. Higher levels of PCT and CRP during sepsis as com-
pared with SIRS or no SIRS have been described previously
Figure 3
Median serum procalcitonin (PCT, ng/ml), C-reactive protein (CRP, mg/dl), sequential o gan failure assessment (SOFA) score and sepsis score (score values) time cour  in s psis (34 patients)
dl), sequential organ failure assessment (SOFA) score and sepsis 
score (score values) time course in sepsis (34 patients). Six nonsurvi-
vors: one in T2, one in T5, one in T6, and three in T8-T9. ■, PCT; , 
CRP; ● , sepsis score; ❍ SOFA score.
Figure 4
Sepsis/SS group: median and 25th/75th percentiles of procalcitonin (PCT), C-reactive protein (CRP), sequential organ failure assessmentSOFA) score and s psis score in nonsurviv s (NS) and survivors (S) at admis ion (AD) and di charge (D)
(PCT), C-reactive protein (CRP), sequential organ failure assessment 
(SOFA) score and sepsis score in nonsurvivors (NS) and survivors (S) 
at admission (AD) and discharge (D). * P < 0.05.
Figure 5
Procalcitonin (PCT)–sequential organ failure assessment (SOFA) cor-relation in infected patients (PCT = -0.84 + 1.526 × SOFA score, ng/m ) and o infected patients (PCT = 0.27 + 0.02 × S FA score, ng/
relation in infected patients (PCT = -0.84 + 1.526 × SOFA score, ng/
ml) and noninfected patients (PCT = 0.27 + 0.02 × SOFA score, ng/
ml). * P < 0.02.  and solid line, infected and regression line; + and 
dashed line, noninfected and regression line.
Figure 6
C-reactive protein (CRP)–sequential organ failure assessment (SOFA) co rela on in infected patients (CRP = 105.58 + 0.72 × SOFA score, mg/l) nd noni f t  ti t  (   84.53 - 0.19 × SOFA, mg/l)
correlation in infected patients (CRP = 105.58 + 0.72 × SOFA score, 
mg/l) and noninfected patients (CRP = 84.53 - 0.19 × SOFA, mg/l). 
Data presented in mg/dl. * P < 0.001.  and solid line, infected and 
regression line; + and dashed line, noninfected and regression line.
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do not indicate a significant difference. As a consequence, the
usefulness of PCT and CRP in discriminating between SIRS
and sepsis is debated.
Whereas a significant increase of PCT during severe sepsis
and septic shock remains undisputed and is the major
strength of PCT, the role of PCT in the discrimination of SIRS,
no SIRS and sepsis is equivocal, although the majority of stud-
ies indicate higher values in patients with sepsis. The ambigu-
ous conclusions of different studies regarding the diagnostic
accuracy of PCT and CRP are mainly due to the lack of a gold
standard for infection, the propagation and misuse of an insen-
sitive assay in the wrong clinical setting (e.g. early infection or
immunocompromised patients), and the negligence of the fact
that, as for all hormones, different cut-off levels have to be
used according to the clinical questions asked. But the defini-
tion of infection is a methodological limitation in all similar
studies.
In the present study, infection was defined when clinical signs
of systemic inflammatory response were present, determined
by a definable source of infection (microbiology confirmed)
and/or positive blood cultures. Therefore, potentially infected
patients with negative cultures would be misclassified into the
SIRS group.
Povoa and colleagues [13] and Mimoz and colleagues [33]
found that the 'normal' plasma CRP level in critically ill patients
rarely lies within the normal range for a healthy population.
CRP also was not useful in distinguishing evolution of sepsis
in severe sepsis and septic shock [34], and septic complica-
Table 2
Procalcitonin (PCT), C-reactive protein (CRP), and lactate plasma levels at various severities of organ dysfunction, categorised 
according to four groups of the sequential organ failure assessment (SOFA) score, comparing patients with and without infection 
and trauma
Category of SOFA score 
(number of observations, 
noninfected/infected)
Noninfected Infected P, noninfected /infected Trauma (number of trauma 
observations)
PCT (ng/ml)
1–6 (n = 180/377) 0.14 (0.08/0.33) 0.62 (0.24/2.12) < 0.001 0.25 (0.08–0.9) (n = 368)
7–12 (n = 24/132) 0.25 (0.2/0.3) 2.43 (1.2/8.68) < 0.001 5.54 (0.86–12.87) (n = 88)
13–18 (n = 1/30) 0.41 8.5 (3.39/29.59) n.s. 54 (15.58–122.4) (n = 9)
19–24 (n = 0/13) - 23.24 (2.28/50.9) - -
Pearson's correlation 0.108 (P = n.s.) 0.247 (P < 0.001) 0.465 (P <0.001)
Regression, y = a + bx 0.27 + 0.02 × SOFA score -0.84 + 1.526 × SOFA 
score
< 0.02 -5 + 2.16 × SOFA score
CRP (mg/l)
1–6 (n = 180/377) 68 (28/121) 121 (68/176) < 0.001 91 (49.8–148) (n = 368)
7–12 (n = 24/132) 47(15/81) 181 (78/271) < 0.001 110 (64–151) (n = 88)
13–18 (n = 1/30) 12.3 183 (128/219) n.s. 94 (n = 9)
19–24 (n = 0/13) - 154 (9.6/308) - -
Pearson's correlation 0.069 (P = n.s.) 0.286 (P < 0.001) 0.095 (P = n.s.)
Regression, y = a + bx 84.53 - 0.19 × SOFA 
score
105.58 + 0.72 × SOFA 
score
< 0.001 95 + 0.24 × SOFA score
Lactate (mmol/l)
1–6 (n = 180/377) 1.21 (0.96/1.44) 1.3 (1.04/1.69) n.s. 1.1 (0.86–1.51) (n = 368)
7–12 (n = 24/132) 1.55 (1.22/3.54) 1.69 (1.2/2.2) n.s. 2.09(1.19–2.61) (n = 88)
13–18 (n = 1/30) 2.8 3.07 (2.25/3.59) n.s. 5.58 (n = 9)
19–24 (n = 0/13) - 3.69 (3.52/5) - -
Pearson's correlation 0.350 (P < 0.002) 0.382 (P < 0.001) 0.431 (P <0.001)
Regression, y = a + bx 0.918 + 0.14 × SOFA 
score
0.968 + 0.12 × SOFA 
score
n.s. 0.516 + 0.235 × SOFA 
score
Data presented as median values (lower and upper quartiles). P value from Mann–Whitney U-test.
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R241tions in patients with trauma [35]; in the late post-traumatic
period, the CRP values remained high [11,18,36]. Elevated
concentrations of serum CRP at admission are correlated with
an increased risk of organ failure and death [37]. In our study,
patients with SIRS or no SIRS also had elevated CRP levels,
but the CRP over time was significantly higher in sepsis/SS
patients. However, during the course of the disease we did not
observe significant changes in the CRP sepsis-related level.
Also, in septic patients, CRP values increased to a maximum
level only at T2–T3 and remained elevated for many days.
The PCT level, on the contrary, remains in the lower range dur-
ing infection or systemic inflammation of less gravity, and high
levels are found during severe sepsis and septic shock. Some
authors found that PCT (and CRP) had poor sensitivity and
specificity for the diagnosis of infection [14]. The
discriminative power is higher for diagnosis of sepsis, severe
sepsis or septic shock [15,34]. In our study, elevated PCT lev-
els closely marked the sepsis versus the SIRS and versus the
no SIRS groups, and also in demarking the severe sepsis and
septic shock groups; during the ICU stay, PCT and CRP val-
ues increased in septic complications. This fact is helpful in
patients with SIRS and when signs of sepsis are misleading
and/or absent. Nevertheless, we observed that in septic
events plasma PCT increased or lowered more quickly than
CRP; perhaps this is related to a more rapid PCT kinetics (Fig.
3). The maximum PCT level in the sepsis/SS group was at T1,
and this kinetic characteristic allows anticipation of a diagno-
sis of sepsis 24–48 hours before the CRP level would.
Day-to-day evaluation of the common parameters are useful to
predict evolution of sepsis and clinical outcome; only patients
who survived presented a significant reduction of CRP level,
PCT level, SOFA score and sepsis score values. In the trauma
group, when infectious complications occurred, the PCT val-
ues rose promptly and marked the septic event. Moreover, we
observed that trauma patients who developed sepsis
presented at ICU admission with higher PCT levels than
patients with a favourable evolution to recovery. These trauma
patients with a higher PCT level at admission are at risk of
infections and must be strictly monitored with bacteriological
samples to recognise septic complications.
For low PCT and CRP plasma values (approximately 0.3–0.6
ng/ml and 60–80 mg/l, respectively), the diagnosis of sepsis
from SIRS is not simple in ICU patients; neither of these two
markers alone possesses good discriminant value, especially
in a heterogeneous mix of diseases. The SIRS concept is sim-
ple but aspecific, and in a patient with sepsis the degree of
sepsis and his/her organ dysfunction cannot be identified by a
single marker. Like other workers, we agree that PCT and CRP
levels may be useful together with full clinical assessment
including signs of sepsis, bacteriological data, and organ func-
tion evaluation [9,37,38]. We found that the increase and
decrease of PCT values correlated with the worsening or the
healing of the sepsis and systemic inflammatory response,
respectively.
Conclusions
The data of the present study indicate that PCT and CRP both
are infection-related parameters. However, both proteins are
also induced during noninfectious causes of systemic inflam-
mation and in patients with organ dysfunction. Both parame-
ters have different kinetics and profiles of induction: the
kinetics of CRP is slower than that of PCT, and CRP concen-
trations are induced near to their maximum also during less
severe symptoms of systemic inflammation and organ dys-
function. Thus, in critically ill patients, both parameters (CRP
and PCT) provide different information. In patients with severe
systemic inflammation, severe sepsis, and organ dysfunction,
PCT has demonstrated itself to be a parameter with a wide
range of concentrations and clinically useful kinetics, thus
being the better parameter of the two to estimate the severity,
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